Shanghai INT Medical Instruments Co

Shanghai INT Medical Instruments Co EPS

Indtjening pr. aktie (EPS) for Shanghai INT Medical Instruments Co (1501.HK) pr. 23. okt. 2026 er 1,47 CNY. I foregående år var Indtjening pr. aktie (EPS) 1,09 CNY — en ændring på 35,01 % (højere).

EPS

1,47CNY

YoY

35,01%

Senest opdateret:

Indtjening pr. aktie (EPS) for Shanghai INT Medical Instruments Co er 2025 1,47 CNY. Indtjening pr. aktie (EPS) for Shanghai INT Medical Instruments Co var 2024 1,09 CNY. Det falder dermed med 35,01% højere sammenlignet med året før.

Shanghai INT Medical Instruments Co EPS historik

  • 3 år

  • 10 år

  • 25 år

  • Maks

EPS
Dato
EPS
1. jan. 2020
0,73 CNY
1. jan. 2021
0,99 CNY
1. jan. 2022
0,90 CNY
1. jan. 2023
0,91 CNY
1. jan. 2024
1,09 CNY
1. jan. 2025
1,47 CNY
1. jan. 2026 (e)
1,46 CNY
1. jan. 2027 (e)
1,68 CNY
Shanghai INT Medical Instruments Co EPS historik
ÅREPSYoY
est1,68CNY+14,39%
est1,46CNY-0,16%
1,47CNY+35,01%
1,09CNY+19,59%
0,91CNY+1,35%
0,90CNY-9,77%
0,99CNY+35,88%
0,73CNY-2,13%
0,75CNY+61,89%
0,46CNY+81,08%
0,25CNY+19,91%
0,21CNY—

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Shanghai INT Medical Instruments Co Aktieanalyse

Hvad laver Shanghai INT Medical Instruments Co? Shanghai Kindly Medical Instruments Co., Ltd. generates revenue through the research and development, manufacturing, and sales of interventional and implantable medical devices. The company's cardiovascular intervention business focuses on cardiovascular interventional medical devices, related molds, and accessories, with main products including inflation device, Introducer set, and guidewire. It serves domestic and overseas markets such as Europe and the United States, targeting healthcare providers and medical institutions that require specialized equipment for minimally invasive procedures. The firm expands its product portfolio beyond cardiovascular devices to include neurological interventional medical devices and endocardia implantable medical devices, catering to diverse clinical needs. Its domestic market presence is complemented by exports to Europe and the United States, where it supplies hospitals and clinics seeking high-quality medical devices for patient care. The company's full-time workforce of 1,532 employees supports these operations, ensuring consistent production and delivery of its medical device solutions. Shanghai Kindly Medical Instruments Co., Ltd. operates with a clear focus on interventional and implantable medical devices, leveraging its R&D capabilities to develop specialized products. Its business model relies on direct sales of these devices to healthcare facilities, with no mention of third-party partnerships or additional revenue streams beyond the core product lines described. Shanghai INT Medical Instruments Co er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Shanghai INT Medical Instruments Co aktie

Indtjening pr. aktie (EPS) for Shanghai INT Medical Instruments Co er 1,47 CNY i 2025.

Indtjening pr. aktie (EPS) for Shanghai INT Medical Instruments Co ændrede sig fra 1,09 CNY til 1,47 CNY, hvilket repræsenterer en ændring på 35,01 %. Værdien er højere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af Indtjening pr. aktie (EPS) Shanghai INT Medical Instruments Co siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

Indtjening pr. aktie måler den del af virksomhedens fortjeneste, der er allokeret til hver udestående aktie, og er en nøglekenntal til vurdering af en virksomheds rentabilitet pr. aktie.

EPS = Nettoindtjening / Udestående aktier

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Resultatopgørelse — Shanghai INT Medical Instruments Co

Alle nøgletal — Shanghai INT Medical Instruments Co